Prosecution Insights
Last updated: October 25, 2026

Sterne, Kessler, Goldstein & Fox PLLC

Technology area: Biotechnology & Pharmaceuticals

682 pending office actions • 234 clients • 591 examiners • 279 art units • 14 of 682 (2%) have an AI response strategy ready

Analysis

STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C. has 680 pending office actions in Biotechnology & Pharmaceuticals and 45,755 career applications. Its resolved allowance rate is 90.36%, with an average of 2.89 office actions per allowance.

The pending workload and career application volume establish a broad prosecution record in biotechnology and pharmaceuticals. A 90.36% resolved allowance rate indicates that most resolved matters reached allowance, while 2.89 office actions per allowance indicates that allowed matters generally required several examination exchanges. For practitioners, the data supports structured docket management, technical coordination, and preparation for iterative claim negotiation.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=45755 apps, methodology: how we score firms)

90.4%
Allowance Rate
n=45755
+0.52σ
Allowance Rate (norm)
n=45755
2.9
OAs to Allowance
n=32590
-0.47σ
OAs to Allow (norm)
n=32590
1007 days
Time to Allowance
n=32590
+3.4pp
Interview Lift
n=45755
25.9%
RCE Rate
n=45755
2.4%
Appeal Rate
n=45755

Rejection Performance (% of received rejections ultimately overcome)

80.6%
§101 Overcome
n=3650
83.2%
§102 Overcome
n=9354
82.8%
§103 Overcome
n=15482
82.9%
§112 Overcome
n=10546

Specialization & Scale

H04L, A61K, G06F
Top CPC Subclasses
19%
Top-3 CPC Share
n=45755
92
Practitioners
n=45755
497.3
Apps / Practitioner
n=45755

Portfolio Summary

682
Total Pending OAs
424
Non-Final OAs
241
Final Rejections
17
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 180 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

81
Overdue
8
Due this week
44
Due this month
32
Due in next 60 days
15
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 180 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (81)Due ≤ 7 days (8)Due ≤ 30 days (44)Due ≤ 60 days (32)Due later (15)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

321
Hard (47%)
287
Medium (42%)
65
Easy (10%)
9
Unknown (1%)

Rejection Statute Mix

BucketCases
§101 only26 (4%)
§101 + other90 (13%)
§103 only208 (30%)
§102 only29 (4%)
§112 only39 (6%)
Double-patenting only26 (4%)
Double-patenting + other50 (7%)
Multi-statute (no §101)205 (30%)
No statute on record9 (1%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

261
Life Sciences
38% of docket
109
Information Tech
16% of docket
39
Communications
6% of docket
86
Semiconductors
13% of docket
180
Mechanical / Eng
26% of docket
7
Business / Other
1% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

6,820 h
Manual time on pending OAs
1,364 h
Time saved (low, 20%)
2,387 h
Time saved (mid, 35%)
59.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BOWEN, ADAM S 4 96.5% +2.3%
JANG, CHRISTIAN Y 4 68.7% +21.0%
ALSOMAIRY, SARAH ABDOALATIF 4 57.4% +30.7%
AVIGAN, ADAM JOSEPH 3 43.7% +16.3%
FRONDA, CHRISTIAN L 3 82.5% +14.3%
STULII, VERA 3 32.7% +24.9%
ALAM, MIRZA F 3 74.4% +33.9%
BRISTOL, LYNN ANNE 3 63.4% +39.8%
ORTEGA, MARTIN NATHAN 3 26.8% +32.8%
HARRIS, BRITTANY SHARON 3 48.7% +35.4%

Quick Wins (5)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
19676472 FOODSTUFF CONTAINING R 1,3 BUTANEDIOL FOR KETOSIS, ENERGY, AND MENTAL CLARITY FRONDA, CHRISTIAN L —
19578476 R-BUTYLENE GLYCOL TOPICAL COMPOSITIONS FOR ANTI-AGING, SKIN PROTECTION AND HAIR TREATMENT FRONDA, CHRISTIAN L —
18770367 SOURCE/DRAIN EPITAXIAL STRUCTURES FOR SEMICONDUCTOR DEVICES BOWEN, ADAM S —
18741963 Contact Structures In Semiconductor Devices BOWEN, ADAM S —
18671732 Contact Structures With Deposited Silicide Layers BOWEN, ADAM S —

Hard Cases (323)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18459715 ELIMINATION OF NEGATIVE COMPONENT OF UNIPOLAR ATRIAL ELECTROGRAM AND SIGNALING OF SAME SCHAETZLE, KENNEDY 168d overdue
16423491 BEAD COMPOSITIONS FOR AQUATIC WEED CONTROL SAEED, ALI S 147d overdue
18232719 METHOD OF FORMING BIOLOGICAL FIELD EFFECT TRANSISTORS INTEGRATED WITH HEATERS BAUMAN, SCOTT E 146d overdue
17714597 SYSTEM AND METHOD FOR A PAYMENT CARD-BASED EXECUTION OF A MULTIPARTY TRANSACTION INVOLVING ELECTRONIC FUNDS DISBURSEMENT MADAMBA, CLIFFORD B 112d overdue
17875206 HARDENED INTERLAYER DIELECTRIC LAYER CRITE, ANTONIO B 100d overdue
13647325 POINT-OF-CARE FLUIDIC SYSTEMS AND USES THEREOF TURK, NEIL N 98d overdue
17311262 COMPOSITIONS FOR STABILIZING BACTERIA AND USES THEREOF MARTIN, RACHEL E 88d overdue
17629091 A METHOD TO ASSIST IN THE EARLY DIAGNOSIS OF PANCREATIC ADENOCARCINOMA BICKHAM, DAWN MARIE 73d overdue

Interview Candidates (29)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18055057 ANALYTE SENSORS FOR SENSING GLUTAMATE AND METHODS OF USING THE SAME JANG, CHRISTIAN Y 42d overdue
17431044 COMBINATIONS OF BINDING MOIETIES THAT BIND EGFR, HER2 AND HER3 ALSOMAIRY, SARAH ABDOALATIF 30d overdue
18026807 ALPHA-AMYLASE VARIANTS FRONDA, CHRISTIAN L 29d overdue
18990538 BED DEVICE SYSTEM AND METHODS ALAM, MIRZA F 21d
19242715 COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE BRISTOL, LYNN ANNE 34d
17556923 SYSTEMS AND METHODS FOR ANALYTE DETECTION ORTEGA, MARTIN NATHAN 34d
18177571 HUMANIZED 3E10 ANTIBODIES, VARIANTS, AND ANTIGEN BINDING FRAGMENTS THEREOF BRISTOL, LYNN ANNE 47d
17755196 MEANS AND METHODS FOR TREATING SUBJECTS WITH HER2 AND HER3 POSITIVE CANCER BRISTOL, LYNN ANNE 70d

Client Portfolio (234 clients)

View all 234 →

Top Art Units

Art UnitApps
379131
373215
164312
289810
28939
16429
16298
28178
16468
17617

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19693152 TEMPERATURE CONTROLLED MATTRESS COVER WITH ZONES Eight Sleep Inc. AVIGAN, ADAM JOSEPH 3794 §103§112 Non-Final OA — Pending May 29, 2026
19676472 FOODSTUFF CONTAINING R 1,3 BUTANEDIOL FOR KETOSIS, ENERGY, AND MENTAL CLARITY Ketoneaid, Inc. FRONDA, CHRISTIAN L 1652 §103DP Non-Final OA — Pending May 13, 2026
19578476 R-BUTYLENE GLYCOL TOPICAL COMPOSITIONS FOR ANTI-AGING, SKIN PROTECTION AND HAIR TREATMENT Ketoneaid, Inc. FRONDA, CHRISTIAN L 1652 §103DP Non-Final OA — Pending Mar 25, 2026
19534368 BEVERAGE CONTAINING R 1,3 BUTANEDIOL Ketoneaid, Inc. STULII, VERA 1791 §102§103 Final Rejection — Pending Feb 09, 2026
19456772 SEARCH SYSTEMS BASED ON USER RELEVANCE AND REWARD GENERATION Roku, Inc. NGUYEN, THUY N 3622 §101 Non-Final OA — Pending Jan 22, 2026
19455116 LED DRIVER IC FOR SCANNING BACKLIGHT CONTROL Roku, Inc. ILUYOMADE, IFEDAYO B 2624 Other Non-Final OA — Pending Jan 21, 2026
19449853 RENDERING A DYNAMIC ENDEMIC BANNER ON STREAMING PLATFORMS USING CONTENT RECOMMENDATION SYSTEMS AND CONTENT MODELING FOR USER EXPLORATION AND AWARENESS Roku, Inc. FOGG, CYNTHIA M 2421 DP Non-Final OA — Pending Jan 15, 2026
19440011 OBJECT INJECTION FRAMEWORK FOR DYNAMIC AND INTERACTIVE SCREENSAVER Roku, Inc. POUNCIL, DARNELL A 3622 §103Other Non-Final OA — Pending Jan 05, 2026
19421562 WEARABLE DEVICES AND METHODS FOR PROVIDING THERAPY TO A USER AND/OR FOR MEASURING PHYSIOLOGICAL PARAMETERS OF THE USER Therabody, Inc. XU, JUSTIN 3791 §103DP Final Rejection — Pending Dec 16, 2025
19410753 FOOTWEAR COMPRISING RIGID CAGE AND VARIABLE PADDING ELEMENT Adidas AG LYNCH, MEGAN E 3732 §102§103 Non-Final OA — Pending Dec 05, 2025
19402343 INNER LINING BOOTIE COMPRISING MEMBRANE MATERIAL Adidas AG MANGINE, HEATHER N 3732 §103§112 Non-Final OA — Pending Nov 26, 2025
19379104 PERSONALIZED RETRIEVAL SYSTEM Roku, Inc. AGHARAHIMI, FARHAD 2161 §112Other Non-Final OA — Pending Nov 04, 2025
19376116 THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING MOVEMENT DISORDERS Vima Therapeutics, Inc. SCHLIENTZ, LEAH H 1618 §103 Final Rejection — Pending Oct 31, 2025
19365921 SYSTEMS AND METHODS FOR CONTROLLING OPERATIONS OF AN ARTICLE OF FURNITURE Eight Sleep Inc. NEWTON, JASON TODD 3673 §102§103 Final Rejection — Pending Oct 22, 2025
19365945 COMBINED MEDIA CAPABILITY FOR MULTIPLE MEDIA DEVICES Roku, Inc. ALATA, YASSIN 2426 DP Non-Final OA — Pending Oct 22, 2025
19359392 MASS INSERTION INTO SINGLE-THREADED DATABASES Roku, Inc. YEN, SYLING 2166 §103 Non-Final OA — Pending Oct 15, 2025
19358181 METHODS OF TREATING TUMORS Halozyme, Inc. BENAVIDES, JENNIFER ANN 1675 §103§112Other Final Rejection 2d overdue Pending Oct 14, 2025
19357282 SECURE REMOTE-LESS CONFIGURATION OF A MEDIA PLAYBACK DEVICE Roku, Inc. PIERORAZIO, MICHAEL 2426 DP Non-Final OA — Pending Oct 14, 2025
19358118 METHOD AND SYSTEM FOR GLYCEMIC PREDICTION AND DYNAMIC VISUALIZATION Abbott Laboratories XU, JUSTIN 3791 §101§103§112 Non-Final OA 56d AI Ready Oct 14, 2025
19356761 CONTEXTUAL-BASED MOTION CONTROL OF A USER INTERFACE Roku, Inc. MONSHI, SAMIRA 2422 §103Other Non-Final OA — Pending Oct 13, 2025
19353277 DEEP MACHINE LEARNING CONTENT ITEM RANKER Roku, Inc. HTAY, LIN LIN M 2153 §101§103 Non-Final OA — Pending Oct 08, 2025
19352550 HIGH QUALITY METADATA CREATION FOR CONTENT USING NOISY SOURCES Roku, Inc. EKPO, NNENNA NGOZI 2425 DP Non-Final OA — Pending Oct 08, 2025
19353317 GENERATING SHORT-FORM CONTENT FROM FULL-LENGTH MEDIA USING A MACHINE LEARNING MODEL Roku, Inc. HUNTER, MISHAWN N 2484 §102§103 Non-Final OA — Pending Oct 08, 2025
19344040 DOUBLE-STRANDED RNAI AGENTS AND COMPOSITIONS FOR REDUCING EXPRESSION OF ANGIOPOIETIN-LIKE 3 (ANGPTL3) AND METHODS OF USE THEREOF Silence Therapeutics GmbH YU, DAVID TUYANG 1635 §103 Non-Final OA — Pending Sep 29, 2025
19336854 AUTOMATIC PARENTAL CONTROL BASED ON AN IDENTIFIED AUDIENCE Roku, Inc. MARANDI, JAMES R 2421 §102§103Other Non-Final OA — Pending Sep 23, 2025
18851486 INFORMATION PROCESSING APPARATUS AND INFORMATION PROCESSING METHOD Legalon Technologies, Inc. LEROUX, ETIENNE PIERRE 2161 §101§102§103 Non-Final OA — Pending Aug 25, 2025
19306598 OUTSOLE FOR A SHOE Adidas AG YE, XINWEN 3732 §102§103 Non-Final OA — Pending Aug 21, 2025
19302239 JAILED ENVIRONMENT RESTRICTING PROGRAMMATIC ACCESS TO MULTI-TENANT DATA Capital One Services, LLC PATEL, DIVESH 3696 §101Other Non-Final OA — Pending Aug 18, 2025
19297947 FC FRAGMENTS THAT BIND FCRN AND METHODS OF USE Paragon Therapeutics, Inc. DAHLE, CHUN WU 1641 §103Other Final Rejection — Pending Aug 12, 2025
19295322 PERCUSSIVE THERAPY DEVICE WITH ELECTRICALLY CONNECTED ATTACHMENT Therabody, Inc. MILLER, CHRISTOPHER E 3785 §103§112 Non-Final OA 13d Pending Aug 08, 2025
19289224 Logistical Management System Airspace Technologies, Inc. SIMPSON, DIONE N 3629 §101Other Non-Final OA — Pending Aug 04, 2025
19275631 R-TRIHEXYPHENIDYL FOR TREATMENT OF MOVEMENT DISORDERS The Children'S Mercy Hospital SCHMITT, MICHAEL J 1629 §102§103 Final Rejection — Pending Jul 21, 2025
19266310 DATA AGGREGATION BASED ON HASH MAP DATA STRUCTURES SAP SE PHAN, TUANKHANH D 2154 §103Other Non-Final OA — Pending Jul 11, 2025
19247631 METHODS AND SYSTEMS FOR GATHERING AND ANALYZING HUMAN BIOLOGICAL SIGNALS Eight Sleep Inc. ALAM, MIRZA F 2688 §103Other Non-Final OA — Pending Jun 24, 2025
19242715 COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE Viridian Therapeutics, Inc. BRISTOL, LYNN ANNE 1643 §103§112DPOther Final Rejection 34d Pending Jun 18, 2025
19240354 SECURE SMART CARD SIGNING DIGITAL DOCUMENTS AND VALIDATION Capital One Services, LLC SHEHNI, GHAZAL B 2499 §101§103Other Non-Final OA — Pending Jun 17, 2025
19237235 FAST BOOT SYSTEM Roku, Inc. BAE, JI H 2176 §103§112Other Non-Final OA — Pending Jun 13, 2025
19233583 HIGH EXPRESSION OF ANIMAL HEME PROTEIN IN PLANTS Moolec Science Limited STOCKDALE, JESSICA NICOLE 1663 §102§112DP Non-Final OA — Pending Jun 10, 2025
19233948 VARIABLE-STEP AUTHENTICATION FOR COMMUNICATIONS IN CONTROLLED ENVIRONMENT Global Tel*Link Corporation JEUDY, JOSNEL 2438 DP Non-Final OA — Pending Jun 10, 2025
19232100 ZERO TOUCH DEPLOYMENT AND DYNAMIC CONFIGURATION Elo Touch Solutions, Inc. PATEL, DHAIRYA A 2453 §101§103 Non-Final OA — Pending Jun 09, 2025
19230482 HIERARCHICAL MANAGEMENT OF MULTIPLE COMMUNICATION NETWORKS Apple Inc. TRAN, JIMMY H 2451 DP Non-Final OA — Pending Jun 06, 2025
19230422 SYSTEMS AND METHODS FOR MANAGING COMMUNICATIONS ACROSS DEVICES IN A RING NETWORK Apple Inc. KAZI, SAYEEM MUHAMMAD 2455 §103 Non-Final OA — Pending Jun 06, 2025
19228224 SUPPORT PLATE CONFIGURED TO BE ARRANGED IN A SOLE STRUCTURE OF A SHOE Adidas AG NUNNERY, GRADY ALEXANDER 3732 §102§103 Final Rejection 29d Pending Jun 04, 2025
19228419 EFFICIENCY AND POWER CONTROL OF TASKS HAVING COMPUTATION BOUND AND MEMORY BOUND PHASES Apple Inc. SONG, HUA JASMINE 2139 §102 Non-Final OA — Pending Jun 04, 2025
19226678 AIRCRAFT STRUCTURE Airbus Operations Limited BONNETTE, RODNEY ANDREW 3733 §102§103§112DP Non-Final OA — Pending Jun 03, 2025
19223354 SYSTEM DISCOVERY AND SIGNALING One Media, LLC BURD, KEVIN MICHAEL 2632 §102DP Non-Final OA — Pending May 30, 2025
19222541 MULTI CHAMBER FLEXIBLE BAG AND METHODS OF USING SAME Adienne Pharma & Biotech SA BOSWORTH, KAMI A 3783 §102§103§112 Non-Final OA — Pending May 29, 2025
19218711 CANDIDATE RANKING FOR CONTENT RECOMMENDATION Roku, Inc. PARRA, OMAR S 2421 §103 Final Rejection — Pending May 27, 2025
19216367 ROBOT TEACHING SYSTEM AND ROBOT CONTROL DEVICE Daihen Corporation EVANS, KARSTON G 3657 §102§103§112 Non-Final OA — Pending May 22, 2025
19211894 VOICE COMMAND RECOGNITION SYSTEM Roku, Inc. MUELLER, PAUL JOSEPH 2657 Other Non-Final OA — Pending May 19, 2025

View all 682 →

Managing Sterne, Kessler, Goldstein & Fox PLLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Sterne, Kessler, Goldstein & Fox PLLC's patent allowance rate?

90.4% of resolved applications prosecuted by Sterne, Kessler, Goldstein & Fox PLLC were allowed, across 45,755 applications in USPTO records.

How many office actions does Sterne, Kessler, Goldstein & Fox PLLC average before allowance?

2.89 office actions per allowed application on average.

How many pending office actions does Sterne, Kessler, Goldstein & Fox PLLC have?

682 pending office actions as of October 2026, for 234 clients, before 591 examiners in 279 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month